期刊文献+

辛二酰苯胺异羟肟酸对人卵巢癌紫杉醇耐药细胞OC3/P存活和凋亡的影响 被引量:5

Effect of suberoylanilide hydroxamic acid on survival and apoptosis of human paclitaxel-resistant ovarian cancer OC3 / P cells
下载PDF
导出
摘要 目的 研究辛二酞苯胺异羟肟酸(SAHA)对人卵巢癌紫杉醇耐药细胞OC3/P存活和凋亡的影响。方法 SAHA 4~64 μmol·L-1与OC3/P细胞作用6,12,24或48 h,用倒置显微镜观察细胞形态的变化,瑞氏吉姆萨染色观察细胞质和细胞核形态的变化,MTT法检测细胞存活率,AnnexinⅤ-FITC/PI双染流式细胞术测定细胞凋亡率,用透射电镜观察细胞内超微结构的变化。结果 倒置显微镜下可见,SAHA 4,16和64 μmol·L-1与OC3/P细胞孵育24 h,可引起OC3/P细胞皱缩,细胞贴壁不良,折光率减弱,活细胞数目减少,且随着SAHA浓度升高细胞形态改变更明显。瑞氏吉姆萨染色发现,SAHA 64 μmol·L-1与OC3/P细胞孵育24 h,使细胞体积减小、细胞质凝集和核固缩。MTT法检测结果表明,SAHA 4~64 μmol·L-1对OC3/P细胞存活具有抑制作用,并存在明显的时间和浓度效应关系,其中SAHA 64 μmol·L-1作用 6,12,24和48 h对OC3/P细胞存活的抑制率分别为(7.1±1.9)%,(14.6±2.0)%,(36.8±2.7)%和(83.3±3.0)%(r=0.891,P〈0.05),SAHA 4,8,16,32和64 μmol·L-1作用48 h对OC3/P细胞存活的抑制率分别为(28.8±1.2)%,(34.8±4.3)%,(52.3±2.8)%,(61.3±4.9)%和(83.3±3.0)%(r=0.966,P〈0.05)。流式细胞术检测结果表明,SAHA 4,16和64 μmol·L-1作用48 h均可诱导OC3/P细胞凋亡(P〈0.05,P〈0.01)。透射电镜观察结果表明,SAHA 4,16和64 μmol·L-1作用24 h,OC3/P细胞核出现典型的凋亡形态变化。结论 SAHA可抑制人卵巢癌紫杉醇耐药细胞OC3/P的存活并诱导其凋亡。 OBJECTIVE To study the effect of suberoylanilide hydroxamic acid (SAHA) on survival and apoptosis of human paclitaxel-resistant ovarian cancer OC3/P cells. METHODS OC3/P cells were treated by SAHA with the concentrations of 4, 8, 16, 32 and 64 μmol ·L-1 for 6, 12, 24 or 48 h. Morphological changes of OC3/P cells were observed under inverted microscope, and the changes of cell nucleus were assessed by Giemsa-Wright staining. The viability of OC3/P cells was detected with MTT assay. The apoptosis rates of OC3/P cells were analyzed by AnnexinⅤ-FITC/PI double staining assay with flow cytometry. Transmission electron microscopy was used for assessing the cells ultrastructure. RESULTS After incubation with SAHA 4,16 and 64 μmol·L-1 for 24 h, OC3/P cells became shrinkage, poor adherence, less refractive, which were more obvious with the increase in SAHA concentration. Giemsa-Wright staining showed that OC3/P cells became cytoplasmic agglutination and karyopyknosis after treated with SAHA 64 μmol·L-1 for 24 h. MTT assay revealed that SAHA could inhibit OC3/P cell survival in a concentration-dependent manner (P〈0.05) and time-dependent manner (P〈0.05). The inhibitory ratios of SAHA at concentration 64 μmol·L-1 for 6, 12, 24 and 48 h were(7.1±1.9)%,(14.6±2.0)%,(36.8±2.7)% and (83.3±3.0)%, respectively(r=0.891,P〈0.05), and SAHA 4-64 μmol·L-1 for 48 h were(28.8±1.2)%,(34.8±4.3)%,(52.3±2.8)%,(61.3±4.9)% and (83.3±3.0)%, respectively(r=0.966,P〈0.05). The results of flow cytometry assay revealed that SAHA 4, 16 and 64 μmol·L-1 for 48 h could induce apoptosis of OC3/P cells (P〈0.05, P〈0.01). The apoptosis characteristics in OC3/P cells were also confirmed by transmission electron microscopy. CONCLUSION SAHA can inhibit the survival and induce apoptosis of human paclitaxel-resistant ovarian cancer OC3/P cells.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2013年第6期966-970,共5页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金(31070996) 国家自然科学基金(31171084)~~
关键词 辛二酞苯胺异羟肟酸 卵巢癌 紫杉醇 耐药细胞OC3 P 细胞凋亡 suberoylanilide hydroxamic acid ovarian cancer paclitaxel drug-resistant cellOC3/P apoptosis
  • 相关文献

参考文献9

  • 1Kim DH, Kim M, Kwon HJ. Histone deacetylase in carci- nogenesis and its inhibitors as anti-cancer agents [ J ]. J Biochem Mol Biol, 2003, 36 ( 1 ) : 110-119.
  • 2Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R. FDA approval summary: vorinostat for treatment of ad- vanced primary cutaneous T-cell lymphoma [ J ]. Oncolo- gist, 2007, 12 ( 10 ) : 1247-1252.
  • 3Jin JS, Tsao TY, Sun PC, Yu CP, Tzao C. SAHA inhibits the growth of colon tumors by decreasing histone deacety- lase and the expression of cyclin D1 and survivin [J]. Pathol Oncol Res, 2012, 18(3) :713-720.
  • 4Lee Y J, Won A J, Lee J, Jung JH, Yoon S, Lee BM, et al. Molecular mechanism of SAHA on regulation of auto- phagic cell death in tamoxifen-resistant MCF-7 breast canc- er cells[J]. Int J Med Sci, 2012, 9(10) ,.881-893.
  • 5Jiang Y. Wang Y, Su Z, Yang L, Guo W, Liu W, et al. Synergistic induction of apoptosis in HeLa cells by the pro- teasome inhibitor bortezomib and histone deacetylase in- hibitor SAHA[J]. Mol Med Rep, 2010, 3(4) :613-619.
  • 6Hess-Stumpp H, Bracker TU, Henderson D, Politz O. MS-275, a potent orally available inhibitor of histone deacetylases- the development of an anticancer agent [J]. Int J Biochem Cell Biol, 2007, 39(7-8) :1388-1405.
  • 7Batty N, Malouf GG, Issa JP. Histone deacetylase inhibi- tors as anti-neoplastic agents[ J]. Cancer Lett, 2009, 280 (2) :192-200.
  • 8YiTZ, LiJ, HanX, GuoJ, QuQ, GuoL, etal. DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo[J]. Chemotherapy, 2012, 58(1 ) :19-29.
  • 9Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, et al. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy [J]. Cancer, 2011, 117 ( 19 ) : 4424-4438.

同被引文献45

  • 1纪巧丽,林蓉,史晓莲,毛幼桦,翟小刚.双丙戊酸钠和丙戊酸钠对HepG2细胞的毒性作用及机制[J].中国药理学与毒理学杂志,2010,24(3):214-218. 被引量:9
  • 2金正均.合并用药中的相加[J].中国药理学报,1980,1(2):70-76.
  • 3Monneret C. Histone deacetylase inhibitors [ J ]. Eur J Med Chem, 2005, 40(1) :1-13.
  • 4Kim DH, Kim M, Kwon HJ, et al. Histone deacetylase in carci- nogenesis and its inhibitors as anti-cancer agents [ J ]. J Biochem Mol Biol, 2003, 36 ( 1 ) : 110 - 119.
  • 5Jiang Y, Wang Y, Su Z, et al. Synergistic induction of apoptosis in HeLa cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitor SAHA [ J ]. Mol Med Report, 2010, 3 (4) : 613 -619.
  • 6Lee YJ, Won AJ, Lee J, et al. Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells [J]. Int J Med Sci,2012,9(10) :881 -893.
  • 7Dinh P, Harnett P, Piccart G, et al. New therapies for ovarian cancer: eytotoxics and molecularly targeted agents [ J]. Crit Rev Oncol Hematol, 2008, 67 ( 2 ) : 103 - 112.
  • 8Chou TC. Drug combination studies and their synergy quantifica- tion using the Chou-Talalay method [ J ]. Cancer Res,2010,70 (2) : 440 -446.
  • 9Schiff PB, Fant J, Horwitz SB . Promotion of microtubule assem- bly in vitro by Taxol [ J ]. Nature, 1979,277 ( 5698 ) : 665 - 667.
  • 10Zhang Y, Li N, Caron C, et al. HDAC45 interacts with and deacetylates tubulin and microtubules in vivo [ J ]. EMBO J, 2003, 22(5) : 1168 -1179.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部